- Clover Health (CLOV, Financial) to join the Russell 3000® Index effective June 30, 2025.
- Membership in the Russell 3000® includes potential inclusion in either the Russell 1000® or Russell 2000® Index.
- Approximately $10.6 trillion in assets are benchmarked against Russell's US indexes.
Clover Health Investments, Corp. (CLOV) is set to enhance its market visibility by joining the broad-market Russell 3000® Index, effective after the US market opens on June 30, 2025. This milestone signifies Clover Health's inclusion among the 3,000 largest publicly traded U.S. companies, marking a significant step in its market presence.
Inclusion in the Russell 3000® Index automatically grants Clover Health membership in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, contingent on its exact market capitalization ranking. This move also extends to the relevant growth and value style indexes, broadening the company's appeal to a wider investment audience.
The financial implications of this development are noteworthy. With approximately $10.6 trillion in assets benchmarked against Russell's US indexes as of June 2024, Clover Health is poised for potential passive investment inflows. Index funds and ETFs tracking these benchmarks will be prompted to acquire shares of CLOV, which could offer technical support to its stock price during the rebalancing phase.
CEO Andrew Toy highlighted the strategic significance of this recognition, emphasizing its role in enhancing visibility among institutional investors. He stated, "This achievement highlights the progress we've made to broaden awareness and engagement with the investment community, as we remain focused on achieving our goals and executing our long-term strategy."
As a company committed to improving healthcare access for Medicare beneficiaries, Clover Health's inclusion in these prestigious indexes represents both an external validation of its growth and an opportunity to attract wider investment interest.
